REVERSE TRANSCRIPTASE in Croatian translation

• reverzne transkriptaze
• reverznu transkriptazu
• povratne transkriptaze
• reverzna transkriptaza
• reverznoj transkriptazi

Examples of using Reverse transcriptase in English and their translations into Croatian

two other nucleoside or nucleotide reverse transcriptase inhibitors.
nukleotidna inhibitora reverzne transkriptaze.

non-nucleoside reverse transcriptase inhibitors(such as efavirenz, nevirapine);
nenukleozidni inhibitori reverzne transkriptaze( kao što su efavirenz, nevirapin);

No apparent evidence of drug interaction was observed in 47 HIV-HCV co-infected patients who completed a 12 week pharmacokinetic substudy to examine the effect of ribavirin on the intracellular phosphorylation of some nucleoside reverse transcriptase inhibitors lamivudine and zidovudine or stavudine.
U 47 bolesnika koinficiranih HIV-om i HCV-om nije jasno dokazana interakcija između lijekova tijekom 12-tjednog farmakokinetičkog podispitivanja učinaka ribavirina na unutarstaničnu fosforilaciju određenih nukleozidnih inhibitora reverzne transkriptaze lamivudin i zidovudin ili stavudin.

RNA viruses that do not need reverse transcriptase because they replicate their nucleus using other types of DNA
potpuno neučinkovit protiv DNA i RNA virusa, koji ne zahtijevaju reverzne transkriptaze, jer je njegova jezgra replicirati druge vrste DNA

The antiviral activity of abacavir in cell culture was not antagonized when combined with the nucleoside reverse transcriptase inhibitors(NRTIs) didanosine, emtricitabine, lamivudine, stavudine, tenofovir or zidovudine, the non-nucleoside reverse transcriptase inhibitor(NNRTI) nevirapine, or the protease inhibitor(PI) amprenavir.
Antivirusna aktivnost abakavira u kulturi stanica nije bila antagonizirana kad se primjenjivao u kombinaciji s nukleozidnim inhibitorima reverzne transkriptaze(NRTI) didanozinom, emtricitabinom, lamivudinom, stavudinom, tenofovirom ili zidovudinom, s nenukleozidnim inhibitorom reverzne transkriptaze(NNRTI) nevirapinom ili inhibitorom proteaze(PI) amprenavirom.

the non-nucleoside reverse transcriptase inhibitor(NNRTI) nevirapine,
nenukleozidnim inhibitorom reverzne transkriptaze(NNRTI) nevirapinom

Efavirenz non-competitively inhibits HIV-1 reverse transcriptase(RT) and does not significantly inhibit human immunodeficiency virus-2(HIV-2) RT
Efavirenz je nekompetitivni inhibitor reverzne transkriptaze virusa HIV-1(RT) i nema svojstvo značajne inhibicije virusa humane imunodeficijencije 2(HIV-2)

A third subject had pre-existing NNRTI resistance-associated substitutions to efavirenz and the M184V reverse transcriptase resistance-associated substitution to emtricitabine at entry into the Atripla extension phase and experienced a suboptimal virologic response,
Treći je ispitanik već imao supstitucije povezane s rezistencijom na efavirenz(NNRTI) i M184V supstituciju reverzne transkriptaze povezanu s rezistencijom na emtricitabin kod uključenja u proširenu fazu ispitivanja Atriple

27 patients treated with Stribild had HIV-1 with the NNRTI-associated K103N substitution in reverse transcriptase at baseline and had virologic success(82% at Week 144)
27 pacijenata liječenih Stribildom imalo je HIV-1 sa supstitucijom K103N povezanom s NNRTI-om u reverznoj transkriptazi na početku ispitivanja, imalo je virološki uspjeh(82% u 144. tjednu)

are being treated with an anti-HIV medicinal product(s)- nucleoside reverse transcriptase inhibitor(NRTI), and/or highly active anti-retroviral therapy HAART.
liječite se lijekom ili lijekovima protiv HIV-a nukleozidnim inhibitorom reverzne transkriptaze( NRTI) i/ ili vrlo djelotvornom antiretrovirusnom terapijom HAART.

3 other classes of antiretrovirals nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors and protease inhibitors.
tri druge skupine antiretrovirusnih lijekova nukleozidne inhibitore reverzne transkriptaze, nenukleozidne inhibitore reverzne transkriptaze i inhibitore proteaze.

nevirapine(200 mg twice daily) and two nucleoside reverse transcriptase inhibitors in 70 single protease inhibitor experienced, non-nucleoside reverse transcriptase inhibitor naïve patients.
plus nevirapin(200 mg dvaput na dan) te dvaju nukleozidnih inhibitora reverzne transkriptaze u 70 bolesnika koji su prethodno primali jedan inhibitor proteaze, ali ne i nenukleozidne inhibitore reverzne transkriptaze.

2 years of age received twice daily fosamprenavir/ ritonavir with background nucleoside reverse transcriptase inhibitor therapy and 5 subjects received only single
2 godine primala fosamprenavir/ritonavir dvaput na dan uz osnovnu terapiju nukleozidnim inhibitorima reverzne transkriptaze, dok je 5 ispitanika primilo samo jednokratnu dozu fosamprenavira s ritonavirom

non nucleoside reverse transcriptase inhibitors, therefore the use of Trizivir should only be considered under special circumstances e.g. co-infection with tuberculosis.
nenukleozidne inhibitore reverzne transkriptaze, te stoga korištenje lijeka Trizivir treba razmotriti samo u posebnim okolnostima npr. u slučajevima istovremene infekcije tuberkulozom.

Study AI266073 was a 48-week open-label randomised clinical study in HIV infected patients comparing the efficacy of Atripla to antiretroviral therapy consisting of at least two nucleoside or nucleotide reverse transcriptase inhibitors(NRTIs) with a protease inhibitor or non-nucleoside reverse transcriptase inhibitor; however not a regimen containing all Atripla components efavirenz, emtricitabine and tenofovir disoproxil fumarate.
Ispitivanje AI266073 bilo je otvoreno randomizirano kliničko ispitivanje od 48 tjedana na pacijentima inficiranima virusom HIV-a u kojem je učinkovitost Atriple uspoređivana s učinkovitošću antiretrovirusne terapije koja se sastoji od najmanje dva nukleozidna ili nukleotidna inhibitora reverzne transkriptaze( NRTI) s inhibitorom proteaze ili ne-nukleozidnim inhibitorom reverzne transkriptaze, ali ne i s režimom koji bi sadržavao sve komponente Atriple efavirenz, emtricitabin i tenofovirdizoproksil fumarat.

Baseline Reverse Transcriptase Mutation.
Početna mutacija reverzne transkriptaze.

Hiv-antiviral agents: reverse transcriptase inhibitors.
Antivirusni lijekovi protiv hiv-a: inhibitori reverzne transkriptaze.

Hiv antiviral agents: reverse transcriptase inhibitors.
Hiv antivirusni lijekovi: inhibitori reverzne transkriptaze.

Nevirapine stops reverse transcriptase from working.
Nevirapin zaustavlja rad reverzne transkriptaze.

Nucleoside/nucleotide reverse transcriptase inhibitors NRTIs.
Nukleozidni/nukleotidni inhibitori reverzne transkriptaze NRTI-jevi.